Sammensetning omfattende anti-TNF-alfa-antistoff for behandling av reumatoid artritt

Methods of treating rheumatoid arthritis via biweekly, subcutaneous administration of 40 mg of the anti-TNF antibody adalimumab (2DE7). The antibody may be administered with or without methotrexate. .

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Weiss, Roberta, Kempeni, Joachim, Fischkoff, Steven A
Format:	Patent
Sprache:	nor
Schlagworte:	CHEMISTRY DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Methods of treating rheumatoid arthritis via biweekly, subcutaneous administration of 40 mg of the anti-TNF antibody adalimumab (2DE7). The antibody may be administered with or without methotrexate. .